Dental Floss Vaccine: A Needle-Free Injection Method
Flossing Your Way to Immunity: A Novel Vaccine Delivery Method Emerges
Lubbock, TX – Imagine a future where getting vaccinated is as simple as flossing your teeth. Researchers at Texas Tech University, in collaboration with other institutions, are making this a reality with a groundbreaking new vaccine delivery technique that targets the junctional epithelium, a crucial interface in the mouth. This innovative approach promises comparable protection to traditional vaccines, with the added benefits of easier administration and a needle-free experience.
the study, published in Nature Biomedical Engineering, details how researchers successfully used dental floss to deliver a flu vaccine to the junctional epithelium, the specialized tissue that lines the gum pocket. This method proved to be as effective as the nasal route, a common alternative for some vaccines, in generating robust immune responses.
“This is extremely promising, becuase most vaccine formulations cannot be given via the nasal epithelium – the barrier features in that mucosal surface prevent efficient uptake of the vaccine,” explained Dr. Bryce Gill,a lead researcher on the project. “Intranasal delivery also has the potential to cause the vaccine to reach the brain, which can pose safety concerns. However, vaccination via the junctional epithelium offers no such risk.”
The team specifically chose a vaccine formulation known to work well via nasal delivery to establish a strong benchmark for comparison. Their findings revealed that the junctional epithelium delivery method not only matched the efficacy of nasal delivery for the flu vaccine but also demonstrated success with other major vaccine types, including protein, inactivated virus, and mRNA vaccines. In all tested cases, the technique elicited significant antibody responses in both the bloodstream and across mucosal surfaces.
Further experiments in animal models indicated that the timing of food and water consumption after flossing with the vaccine did not impact the immune response, simplifying the administration process.
Recognizing that asking individuals to handle vaccine-coated floss directly might be impractical, the researchers adapted their method using a floss pick. To test the feasibility of this approach in humans, they recruited 27 participants. After explaining the concept, participants were asked to deposit a fluorescent food dye into their epithelial junction using a floss pick.
“We found that approximately 60% of the dye was deposited in the gum pocket, which suggests that floss picks may be a practical vaccine delivery method to the epithelial junction,” stated Dr. Saurabh Ingole,another key researcher.
The team is optimistic about the potential for this technique to move towards clinical trials. Beyond the enhanced mucosal immunity, the advantages are significant.”for example, it would be easy to administer, and it addresses concerns many people have about being vaccinated with needles,” Dr. Gill noted. The researchers also anticipate that the cost of this method would be comparable to existing vaccine delivery techniques.
Though,the researchers acknowledge certain limitations. The technique would not be suitable for infants and toddlers who have not yet developed teeth. Additionally, further research is needed to understand how this method would perform in individuals with gum disease or other oral infections.
The study, titled “Floss-based vaccination targets the gingival sulcus for mucosal and systemic immunization,” was supported by grants from the National Institutes of Health (NIH) and funds from the whitacre Endowed Chair in Science and Engineering at texas Tech University.Drs. Gill, Ingole, and Akhilesh Kumar Shakya are co-inventors on a patent related to targeting the junctional epithelium for vaccination. This innovative approach could revolutionize vaccine delivery, making immunization more accessible and less daunting for populations worldwide.